GMED as reported
Globus Medical, Inc. reported $3.10B of revenue over the trailing twelve months, +23% on the year before. 10 reported series are charted on this page, each one as filed.
$3.10B
Revenue, trailing twelve months · to Q1 2026 · +23% against the twelve months before
- Net Income
- $587M
Net Income · +216% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $610M
Free Cash Flow · +17% year on year · trailing twelve months to Q1 2026
- Op Margin
- 17%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $3.10B | +23% | Q1 2026 |
| Net Income | $587M | +216% | Q1 2026 |
| EPS | $4.29 | +220% | Q1 2026 |
| Gross Margin | 68% | n/a | Q1 2026 |
| Op Margin | 17% | n/a | Q1 2026 |
| Net Margin | 19% | n/a | Q1 2026 |
| ROE | 11% | n/a | Q1 2026 |
| ROA | 9.1% | n/a | Q1 2026 |
| Free Cash Flow | $610M | +17% | Q1 2026 |
| P/E | 19.4 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Globus Medical, Inc. (GMED) - Revenue & ProfitRevenue & ProfitGlobus Medical, Inc. (GMED)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com